Relations between SCUBE3 or SP1 expression and clinicopathologic characteristics and prognosis of patients with breast cancer_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

YUAN Qinghui ¹ , XIE Gang ¹ , WANG Anqun ¹ ,  HE Wei ²

1. Department of Pathology, Mianyang Central Hospital, Mianyang, Sichuan 621000, P. R. China;
2. Department of Pain, Mianyang Central Hospital, Mianyang, Sichuan 621000, P. R. China;

Corresponding?author：

HE Wei, Email: hewei5413@163.com

Keywords：

breast cancer; signal peptide-CUB-EGF-like domain containing protein 3; specificity protein 1; clinicopathologic characteristics; prognosis

DOI：

10.7507/1007-9424.202104051

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To detect the expressions of signal peptide-CUB-EGF-like domain containing protein 3 (SCUBE3) and specificity protein 1 (SP1) in breast cancer tissues, and explore relations between their protein expressions and clinicopathologic features or prognosis.Methods From February 2013 to October 2015, the breast cancer tissues and the corresponding adjacent normal breast tissues of 80 women patients with breast cancer in the Mianyang Central Hospital were selected, and the expressions of SCUBE3 and SP1 proteins in the tissues were detected by immunohistochemistry. The relations between the expressions of SCUBE3 and SP1 and clinicopathologic parameters of breast cancer were analyzed, the correlation between the SCUBE3 and SP1 was analyzed by Spearman rank correlation analysis. Kaplan-Meier method was used to analyze the survival of patients with breast cancer; and Cox proportional hazards regression model was used to analyze the risk factors of overall survival of patients with breast cancer.Results The positive rates of SCUBE3 and SP1 proteins expressions in the breast cancer tissues were higher than those in the corresponding adjacent normal breast tissues (P<0.05). The positive rates of SCUBE3 and SP1 protein expressions were higher in the breast cancer tissues with lymph node metastasis and molecular subtypes of Luminal A or B (P<0.05), and the positive rates of SCUBE3 protein expression were higher in the breast cancer tissues with TNM stage Ⅱ–Ⅳ and high Ki67 (P<0.05). The retsult of Spearman rank correlation analysis showed that the positive rates of SCUBE3 and SP1 proteins expressions in the breast cancer tissues was positive correlation (χ²=7.979, r_s=0.316, P=0.005). Kaplan-Meier curve showed that the overall survival of the patients with positive expression of SCUBE3 or SP1 protein was worse than that of the patients with negative expression (χ²=4.042, P=0.044; χ²=10.676, P=0.001). The Cox proportional hazards regression model multivariate analysis showed that the positive SCUBE3 (HR=6.020, P=0.016), positive SP1 (HR=4.077, P=0.018), lymph node metastasis (HR=3.518, P=0.017), and higher Ki67 expression (HR=7.989, P<0.001) were the independent risk factors of overall survival for the patients with breast cancer.Conclusion Positive rates of SCUBE3 and SP1 proteins expressions in breast cancer tissues are higher and there is a positive correlation between them, which are closely related to clinicopathologic parameters such as lymph node metastasis and molecular subtypes and prognosis of patients with breast cancer.

Citation： YUAN Qinghui, XIE Gang, WANG Anqun, HE Wei. Relations between SCUBE3 or SP1 expression and clinicopathologic characteristics and prognosis of patients with breast cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2022, 29(1): 72-77. doi: 10.7507/1007-9424.202104051 Copy

1.	康佳, 吳桐, 張蕾, 等. 不同分子分型乳腺癌的多模態超聲特征和臨床病理對照研究. 中華超聲影像學雜志, 2020, 29(4): 330-336.
2.	Kayali M, Abi Jaoude J, Tfayli A, et al. Post-mastectomy radiation therapy in breast cancer patients with 1–3 positive lymph nodes: No one size fits all. Crit Rev Oncol Hematol, 2020, 147: 102880.
3.	邱鵬飛, 王永勝. 乳腺癌內乳淋巴結精準分期與個體化治療. 中國腫瘤外科雜志, 2020, 12(4): 306-310, 315.
4.	Andersson Y, Bergkvist L, Frisell J, et al. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. Breast Cancer Res Treat, 2018, 171(2): 359-369.
5.	Wu YY, Peck K, Chang YL, et al. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Oncogene, 2011, 30(34): 3682-3693.
6.	Liu X, Wang LG, Zhang LC, et al. Molecular cloning, tissue expression pattern, and copy number variation of porcine SCUBE3. Genet Mol Res, 2016, 15(1): gmr7010.
7.	Huo Q, He X, Li Z, et al. SCUBE3 serves as an independent poor prognostic factor in breast cancer. Cancer Cell Int, 2021, 21(1): 268.
8.	孔祥泉, 曾毅, 王立峰, 等. 乳腺癌組織中 SCUBE2 表達與臨床病理特征的相關性研究. 慢性病學雜志, 2016, 17(8): 845-849.
9.	Torabi B, Flashner S, Beishline K, et al. Caspase cleavage of transcription factor Sp1 enhances apoptosis. Apoptosis, 2018, 23(1): 65-78.
10.	Zhang KF, Wang J, Guo J, et al. Metformin enhances radiosensitivity in hepatocellular carcinoma by inhibition of specificity protein 1 and epithelial-to-mesenchymal transition. J Cancer Res Ther, 2019, 15(7): 1603-1610.
11.	史曉宇, 張敬, 孟瑋, 等. 轉錄因子 Sp1 和存活素在乳腺癌中的表達及相關性研究. 實用腫瘤學雜志, 2017, 31(2): 107-111.
12.	劉裔莎, 魏兵, 楊雯娟, 等. 美國癌癥聯合會乳腺癌分期(第七版)簡介. 中華病理學雜志, 2010, 39(11): 787-790.
13.	Bliss SA, Paul S, Pobiarzyn PW, et al. Evaluation of a developmental hierarchy for breast cancer cells to assess risk-based patient selection for targeted treatment. Sci Rep, 2018, 8(1): 367.
14.	盧小冬. 長鏈非編碼 RNA 牛磺酸調節基因 1 和 miR-132 的表達與乳腺癌預后的關系. 中華普通外科學文獻(電子版), 2020, 14(1): 5-9.
15.	Said NM. Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH). Mol Biol Rep, 2019, 46(2): 2013-2027.
16.	Su F, Geng J, Li X, et al. SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab-resistant ovarian cancer model. Oncol Rep, 2017, 38(5): 2677-2684.
17.	Bolay?r HA, Güne? H, K?vrak T, et al. The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction. Anatol J Cardiol, 2017, 18(2): 122-127.
18.	Yang X, Hu J, Shi C, et al. Activation of TGF-β1 pathway by SCUBE3 regulates TWIST1 expression and promotes breast cancer progression. Cancer Biother Radiopharm, 2020, 35(2): 120-128.
19.	李俊, 李國慶. 新型分泌型蛋白 SCUBE1 在急性冠脈綜合征中促進無復流的研究進展. 新疆醫學, 2018, 48(1): 91-93.
20.	Chen JH, Kuo KT, Bamodu OA, et al. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of Notch signaling and epithelial-to-mesenchymal transition. Exp Cell Res, 2018, 370(2): 444-453.
21.	Monteleone E, Orecchia V, Corrieri P, et al. SP1 and STAT3 functionally synergize to induce the RhoU small GTPase and a subclass of non-canonical WNT responsive genes correlating with poor prognosis in breast cancer. Cancers (Basel), 2019, 11(1): 101.
22.	韓亮, 張麗榮, 趙峰. 轉錄因子特異性蛋白 1 對三陰乳腺癌 HCC1806 細胞增殖凋亡的影響及其機制. 中華實驗外科雜志, 2020, 37(7): 1201-1204.
23.	Lee YJ, Kim WI, Kim SY, et al. Flavonoid morin inhibits proliferation and induces apoptosis of melanoma cells by regulating reactive oxygen species, Sp1 and Mcl-1. Arch Pharm Res, 2019, 42(6): 531-542.
24.	黎三艷, 鄭眉嵩, 陳余鵬, 等. 孕激素抗體 EP2、SP2、1E2、16 在非特殊型浸潤性乳腺癌的表達差異. 第三軍醫大學學報, 2020, 42(10): 1042-1046.
25.	Zhang S, Huang P, Dai H, et al. Timeless regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer. Cell Death Dis, 2020, 11(10): 892.

1. 康佳, 吳桐, 張蕾, 等. 不同分子分型乳腺癌的多模態超聲特征和臨床病理對照研究. 中華超聲影像學雜志, 2020, 29(4): 330-336.
2. Kayali M, Abi Jaoude J, Tfayli A, et al. Post-mastectomy radiation therapy in breast cancer patients with 1–3 positive lymph nodes: No one size fits all. Crit Rev Oncol Hematol, 2020, 147: 102880.
3. 邱鵬飛, 王永勝. 乳腺癌內乳淋巴結精準分期與個體化治療. 中國腫瘤外科雜志, 2020, 12(4): 306-310, 315.
4. Andersson Y, Bergkvist L, Frisell J, et al. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. Breast Cancer Res Treat, 2018, 171(2): 359-369.
5. Wu YY, Peck K, Chang YL, et al. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Oncogene, 2011, 30(34): 3682-3693.
6. Liu X, Wang LG, Zhang LC, et al. Molecular cloning, tissue expression pattern, and copy number variation of porcine SCUBE3. Genet Mol Res, 2016, 15(1): gmr7010.
7. Huo Q, He X, Li Z, et al. SCUBE3 serves as an independent poor prognostic factor in breast cancer. Cancer Cell Int, 2021, 21(1): 268.
8. 孔祥泉, 曾毅, 王立峰, 等. 乳腺癌組織中 SCUBE2 表達與臨床病理特征的相關性研究. 慢性病學雜志, 2016, 17(8): 845-849.
9. Torabi B, Flashner S, Beishline K, et al. Caspase cleavage of transcription factor Sp1 enhances apoptosis. Apoptosis, 2018, 23(1): 65-78.
10. Zhang KF, Wang J, Guo J, et al. Metformin enhances radiosensitivity in hepatocellular carcinoma by inhibition of specificity protein 1 and epithelial-to-mesenchymal transition. J Cancer Res Ther, 2019, 15(7): 1603-1610.
11. 史曉宇, 張敬, 孟瑋, 等. 轉錄因子 Sp1 和存活素在乳腺癌中的表達及相關性研究. 實用腫瘤學雜志, 2017, 31(2): 107-111.
12. 劉裔莎, 魏兵, 楊雯娟, 等. 美國癌癥聯合會乳腺癌分期(第七版)簡介. 中華病理學雜志, 2010, 39(11): 787-790.
13. Bliss SA, Paul S, Pobiarzyn PW, et al. Evaluation of a developmental hierarchy for breast cancer cells to assess risk-based patient selection for targeted treatment. Sci Rep, 2018, 8(1): 367.
14. 盧小冬. 長鏈非編碼 RNA 牛磺酸調節基因 1 和 miR-132 的表達與乳腺癌預后的關系. 中華普通外科學文獻(電子版), 2020, 14(1): 5-9.
15. Said NM. Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH). Mol Biol Rep, 2019, 46(2): 2013-2027.
16. Su F, Geng J, Li X, et al. SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab-resistant ovarian cancer model. Oncol Rep, 2017, 38(5): 2677-2684.
17. Bolay?r HA, Güne? H, K?vrak T, et al. The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction. Anatol J Cardiol, 2017, 18(2): 122-127.
18. Yang X, Hu J, Shi C, et al. Activation of TGF-β1 pathway by SCUBE3 regulates TWIST1 expression and promotes breast cancer progression. Cancer Biother Radiopharm, 2020, 35(2): 120-128.
19. 李俊, 李國慶. 新型分泌型蛋白 SCUBE1 在急性冠脈綜合征中促進無復流的研究進展. 新疆醫學, 2018, 48(1): 91-93.
20. Chen JH, Kuo KT, Bamodu OA, et al. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of Notch signaling and epithelial-to-mesenchymal transition. Exp Cell Res, 2018, 370(2): 444-453.
21. Monteleone E, Orecchia V, Corrieri P, et al. SP1 and STAT3 functionally synergize to induce the RhoU small GTPase and a subclass of non-canonical WNT responsive genes correlating with poor prognosis in breast cancer. Cancers (Basel), 2019, 11(1): 101.
22. 韓亮, 張麗榮, 趙峰. 轉錄因子特異性蛋白 1 對三陰乳腺癌 HCC1806 細胞增殖凋亡的影響及其機制. 中華實驗外科雜志, 2020, 37(7): 1201-1204.
23. Lee YJ, Kim WI, Kim SY, et al. Flavonoid morin inhibits proliferation and induces apoptosis of melanoma cells by regulating reactive oxygen species, Sp1 and Mcl-1. Arch Pharm Res, 2019, 42(6): 531-542.
24. 黎三艷, 鄭眉嵩, 陳余鵬, 等. 孕激素抗體 EP2、SP2、1E2、16 在非特殊型浸潤性乳腺癌的表達差異. 第三軍醫大學學報, 2020, 42(10): 1042-1046.
25. Zhang S, Huang P, Dai H, et al. Timeless regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer. Cell Death Dis, 2020, 11(10): 892.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Relations between SCUBE3 or SP1 expression and clinicopathologic characteristics and prognosis of patients with breast cancer

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content